biomiq represents the evolution away from generic, supplementary health and wellness products, towards a more targeted, microbiome therapeutic treatment approach for chronic health conditions.
We are proud to be located on the picturesque Sunshine Coast of Queensland, Australia.
biomiq started in 2017, when a group of Australia’s leading microbiome scientists commenced developing new, high-quality, and scientifically backed microbiome therapeutic products that people can trust.
biomiq started from selling just a few bottles to friends and family, to selling hundreds of bottles Australia-wide via word-of-mouth recommendations only. Now we are moving to the next phase of our business development to be Australia's No.1 leading microbial therapy provider.
We do not base our marketing on big CFU numbers, innumerable strains of bacteria, or so-called 'fairy-dusting' (adding sub-potent levels of active ingredients).
Instead, we create products that are targeted for specific health conditions, with specific strains at specific active concentrations, in-line with the latest clinical research.
We are also devoted to delivering free, unbiased education resources to the public regarding the importance of the microbiome to human health. We do this as we believe the microbiome is the next frontier for western medicine and may hold the missing link to better understanding many chronic health conditions and illnesses.
Our objective is simple:
One of our key strengths is that we are closely linked with one of Australia’s leading clinical research companies: Servatus Ltd.
Servatus is global leader in developing new and forward-thinking medical treatments, such as live microbial biotherapies. Servatus runs human clinical trials for a range of autoimmune conditions, such as Rheumatoid Arthritis and Inflammatory Bowel Disease, and aims to bring new and highly efficacious prescription medications to market.
Servatus is also one of eight companies forming the Microbiome Therapeutics Innovation Group which was founded to drive forward FDA, TGA, and EMA regulations for new and emerging therapies, such as live microbial biotherapeutic products.
This innovative and important research is driving forward understanding of the microbiome in human health and means we, at biomiq, are able to provide better products to you.
In addition to innovative research and development, and ongoing clinical trials, Servatus Ltd also owns a state-of-the-art production facility in Queensland.
Having access to a world-class production facility means that we are able to oversee all aspects of the product development and production, thus ensuring that our live microbial biotherapeutic products are made to our high standards and specifications.
"We wanted to make something that we could be proud of, that we know is of the highest standard, and based on solid scientific research and third-party testing.
We research, develop, and produce all our products right here in Queensland, Australia. As we control all aspects of our product development, we know exactly what goes into our products, why we are using these specific strains, and where all our ingredients came from. That means we can be sure our products are of the highest calibre."